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Abstract
The aim was to explore the possibility to forecast a risk of hypoxic lesions in a monot-
onous fetal heart rate via ECG measurements by the methods of time and frequency 
analysis. The study involved 50 healthy pregnant women with singleton pregnancy at 
37-41 weeks of gestation along with 17 pregnant women in the same period of gestation 
who had a monotonous fetal heart rate registered of various origin. The registration of 
fetal heart rates was performed using fetal monitor “Monica AN24” (“Monica Healthcare 
Ltd”, United Kingdom), transabdominal, using ECG electrodes. The software package 
“Monica DK” has been used to retrieve the “beat-to-beat” data. Analysis of experimental 
data was carried out on the basis of LABVIEW® software (National Instruments®, USA). 
The analysis of time parameters for fetal hypoxia showed a sharp decline in the spread 
function and a sharp increase in the concentration function. Spectral analysis showed a 
significant decrease in the ratio of high- to low-frequency components of the spectrum. In 
the analysis of fetal ECG, the ST segment depression was noted, which is also indicative 
of fetal hypoxia.
Keywords: cardiotocography, ECG measurements, time HRV analysis, frequency HRV 
analysis, fetal hypoxia
1. Introduction
Cardiotocography (CTG) belongs to routine methods of fetal monitoring in modern obstet-
rics. Doppler heart monitors that use ultrasound to register fetal heart rate allow the assess-
ment of heart rate variability (HRV) and designation of monotonous heart rate as an adverse 
prognostic parameter. Beyond that account must be taken of the fact that over 25% of car-
diotocography (CTG) records in the antenatal period are defined as vague, i.e., deemed alarm-
ing. It basically refers to the monotonicity of fetal heart rate.
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
Attribution L cense (http://creativecommons. /licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
A monotonous heart rate is a rate with the amplitude not exceeding five heart beats per min-
ute absent accelerations or decelerations. A series of successive heart rate values has a complex 
wave structure rather than presents a set of random numbers. Heart rate is largely affected by 
the autonomic nervous system. The impact thereof is manifested in altering various frequency 
components of heart rate oscillations [1]. The degree of the autonomic nervous system impact 
on the fetal cardiac function can be estimated by using standard time and frequency domain 
methods of HRV analysis. Recent years have seen the appearance of scientific papers on the 
interaction of the sympathetic and parasympathetic divisions of the autonomic nervous sys-
tem [2–5]. However, ultrasonic CTG is limited in its further development due to the inability 
to provide its user with the beat-to-beat data required for HRV time and frequency analysis.
External noninvasive registration of fetal heart rate via ECG measurements is another method 
employed in fetal HRV study. Stable ECG signal generation alongside with fetal electrocar-
diogram morphology analysis has become the focus of numerous research investigations [6]. 
These are complemented with papers on the spectral analysis of transabdominal fetal electro-
cardiograms used for diagnosing fetal hypoxia during childbirth [7, 8]. Fetal electrocardiog-
raphy is currently considered as an alternative to Doppler ultrasonic cardiotocography so far 
as the antenatal assessment of fetal condition is.
The present research is targeted toward the exploration of possibilities to predict the risks of 
hypoxic damage in the presence of monotonous fetal heart rate via ECG measurements with 
the application of time and frequency analysis methods.
2. Methods and materials
The sample of the research included 50 patients with normal singleton 37–41 week gestation 
admitted to the maternity department for delivery and 17 patients with the same gestation age 
diagnosed a monotonous fetal heart rate of varied etiology. Medical tests and measurements 
were conducted in the morning hours. Fetal heart rate was registered by using the “Monica 
AN24” (“Monica Healthcare Ltd” GBR)” fetal monitor, transabdominally, with the aid of ECG 
electrodes, the patient’s position being unrestricted. The “Monica DK” software package permit-
ting to retrieve beat-to-beat data was used for analyzing the electrophysiological information.
Each fetal heart rate monitoring session lasted for 60 minutes, which corresponded to 7000 
counts. To avoid mistakes in spectral analysis data interpretation, it is essential that the num-
ber of readings taken for comparison be equal. The following periods of the fetal cardioryth-
mogram were selected for analysis: a stationary period lasting for 5 minutes (700 counts, 
Figure 1), nonstationary period lasting for 5 minutes (700 counts, Figure 2),and integrated 
period lasting for 60 minutes (7000 counts, Figure 3).
The background processing of data for temporal and spectral analysis consisted in the presen-
tation of data in milliseconds (ms), elimination of artifacts (Figures 4 and 5), deletion of pop-
up values using the “three sigma rule” (Figures 6 and 7), and estimation of stationarity using 
the Dx-statistics. Test data analysis was conducted on the basis of the LABVIEW® (National 
Instruments®, USA) software.
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Normative time and frequency parameters for fetal HRV were determined in the group of 
patients with the normal gestation course. The parameters were defined as the upper (95‰) 
and lower (5‰) percentile limits of performance. All basic HRV functions were assessed: 
Figure 1. Stationary period of fetal cardiorythmogram. A duration of 700 counts (Y-axis—RR intervals, ms; X-axis–count).
Figure 2. Nonstationary period of fetal cardiorythmogram. A duration of 700 counts (Y-axis—RR intervals, ms; 
X-axis–count).
Figure 3. Integrated period of fetal cardiorythmogram. A duration of 7000 counts (Y-axis—RR intervals, ms; 
X-axis—count).
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 scattering, concentration, and vegetal balance. The scattering function was tested by applying 
the indicators of standard RR interval distribution. The concentration function was assessed by 
mode parameters. Vegetal balance was tested utilizing the spectral analysis parameters as well 
as the fast-Fourier-transform algorithm. The ECG morphological analysis contained amplitude 
and time parameters. To overcome random interferences with the low ECG signal, we ana-
lyzed the average PQRST cycle (500–1000 cardiocycles) rather than every single cycle (Table 1).
Figure 5. Fetal cardiorythmograms without artifacts (Y-axis—RR intervals, ms; X-axis—count).
Figure 6. Fetal cardiorythmograms with pop-up values (green highlighting) (Y-axis—RR intervals, ms; X-axis—count).
Figure 4. Fetal cardiorythmograms with artifacts (Y-axis—RR intervals, ms; X-axis—count).
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The data correlation analysis permitted to identify five independent indicators to give the 
assessment of the fetal hypoxic damage risk by points (SDNN, RMSSD, AMo, Total Power, 
LF/HF). Assessment of fetal anoxic damage risk: 0–4 point—low; 5–6 point—medium; 7–8 
point—high; 9–10 point—very high (Table 2).
Figure 7. Fetal cardiorythmograms without pop-up values (Y-axis—RR intervals, ms; X-axis—count).
The scattering function
SDNN ms Standard deviation of all NN intervals
RMSSD ms The square root of the mean of the sum of the squares of differences between 
adjacent NN intervals
SDANN ms Standard deviation of the averages of NN intervals in all 5-minute segments of 
the entire recording
NN15 Number of pairs of adjacent NN intervals differing by more than 15 ms in the 
entire recording; three variants are possible counting all such NN interval pairs 
or only pairs in which the first or the second interval is longer
PNN15% % NN15 count divided by the total number of all NN intervals
VR ms Difference between the maximum and the minimum RR intervals
The concentration function
NModa Number of cardio intervals corresponding to the mode value
AMo % Ratio of the amount of RR intervals with the values equaling the mode value to 
the total number of RR intervals, measured in percent
Moda
range
% Percent of cardio intervals in the mode range taken off the total number of RR 
intervals, measured in percent
AMo/PNN15 % Ratio of Amo to the percentage of successive RR intervals with the difference 
exceeding 15 ms
St. George Index Ratio of the histogram area to the amount of intervals with higher sampling rate 
duration
The spectral analysis
VLF ms2 Very low frequency range. Power in VLF range 0.02–0.08 Hz
LF ms2 Low-frequency range. Power in LF range 0.08–0.2 Hz
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3. Results
3.1. Normative, time, and spectral HRV parameters
The gross findings for the patients with normal 37–41 week gestation are as such. Wide vari-
ability of the stationary/nonstationary period parameters taken into account, it is of utmost 
importance to determine the lower (5‰) and the upper (95‰) heart rate percentile limits.
The stationary period (5 minutes or 700 counts, Table 3) is characterized by the monotonicity 
of fetal heart rate continuing for 10–15 minutes in a 60-minute registration session (Table 3). 
It corresponds to the resting or dormant state of the fetus.
IM* ms2 Intermediate-frequency range. Power in IM range 0.2–0.4 Hz
HF ms2 High-frequency range. Power in HF range 0.4–1 Hz
VLF% (AR) % Power in VLF range 0.02–0.08 Hz
LF% (AR) % Power in LF range 0.08–0.2 Hz
HF% (AR) % Power in HF range 0.4–1 Hz
Total power (AR) ms2 Variance of all NN intervals
LF/HF (AR) Ratio LF [ms2]/HF[ms2]
The ECG morphological analysis
Wave P mv Wave amplitude P
Wave Q mv Wave amplitude Q
Wave R mv Wave amplitude R
Wave S mv Wave amplitude S
Wave T mv Wave amplitude T
Interval QRS ms Interval duration QRS
Interval ST ms Interval duration ST
Interval ST mV Segment ST Amplitude
Note: *Parameters exceed the 5–95‰ limits.
Table 1. All basic parameters, HRV functions, and the ECG morphological analysis.
Variable//Point 0 1 2
SDNN >95‰ 5–95‰ <5‰
RMSSD >95‰ 5–95‰ <5‰
AMo <5‰ 5–95‰ >95‰
Total power 5–95‰ >95‰ <5‰
LF/HF 5–95‰ >95‰ <5‰
Table 2. Assessment of fetal anoxic damage risk.
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The nonstationary period (5 minutes or 700 counts, Table 4) is characterized by the fetal heart 
rate acceleration occurrences (Table 4). It corresponds to the motion activity of the fetus.
Integrated period (60 minutes or 7000 counts, Table 5) is characterized by the fetal heart rate 
acceleration and by the monotonicity of fetal heart rate.
It should be noted that time and frequency domain methods used to assess fetal HRV comple-
ment each other.
3.2. Time and spectral HRV parameters and ECG morphology in the presence of 
monotonous fetal heart rate
According to the etiological factor, three types of monotonous fetal heart rate can be identified:
1. Physiological—occurring because of a temporary decrease in the fetus regulatory centers 
activity and corresponding to the resting or dormant state of the fetus;
2. Pharmacological—caused by the suppression of activity of the central fetal heart rate regu-
lation mechanisms (methyldopa and relanium) or by the block of impulse transmission to 
the sino-atrial node (atropine);
3. Hypoxic—conditioned by circulatory injuries in the presence of heart failure or intra-uter-
ine infection.
Since heart rate monotonicity is a stationary cardiorhythmogram, which means that the 
spectral properties of the signal do not change in time, the comparative study of the HRV 
time and frequency analysis data was conducted for the referential values of the stationary 
period only.
Scattering function
SDNN rMSSD NN15 pNN15% VR
5‰ 0.006 0.004 4 0.51 0.04
95‰ 0.012 0.01 35 5.08 0.097
Concentration function
NModa AMo Moda
range
AMo/PNN15 St. George Index
5‰ 32 5.0 48 0.5 13
95‰ 90 12.9 87 4.7 35
Spectral analysis
VLF LF HF VLF% (AR) LF% (AR) HF% (AR) TP LF/HF (AR)
5‰ 0.3 1.9 1.3 5 49 12 4.3 1.15
95‰ 2.9 18.8 5.8 11 78 40 18.5 3.96
Table 3. The stationary period. Lower (5‰) and upper (95‰) percentile limits of the fetal HRV time parameters.
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3.2.1. Physiological monotonicity
Physiological fetal heart rate monotonicity is registered during the dormant state of the fetus 
and continues for 10–15 minutes in a 60-minute cardiac cycle registration session. Here, we 
present data analysis of the patient with 40 week gestation: delivery of a baby boy, 3430 g, 54 cm, 
and 9/9 Apgar score and stationary period lasting for 5 minute(or 700 counts duration, Figure 8 
and Table 6).
Scattering function
SDNN rMSSD NN15 pNN15% VR
5‰ 0.017 0.005 9 1.2 0.09
95‰ 0.033 0.01 71 10.3 0.16
Concentration function
NModa AMo Moda
range
AMo/PNN15 St. George Index
5‰ 19 2.7 29 0.2 29
95‰ 41 5.6 42 1.2 45
Spectral analysis
VLF LF HF VLF% (AR) LF% (AR) HF% (AR) TP LF/HF (AR)
5‰ 1.2 12 2.8 8 63 8 26 2.6
95‰ 17.2 80 11 18 81 24 96 6.8
Table 4. The nonstationary period. Lower (5‰) and upper (95‰) percentile limits of the fetal HRV time parameters.
Scattering function
SDNN rMSSD NN15 pNN15% VR
5‰ 0.017 0.006 234 3.4 0.13
95‰ 0.03 0.011 621 10.8 0.19
Concentration function
NModa AMo Moda
range
% AMo/PNN15 St. George Index
5‰ 150 2.1 27 0.2 32
95‰ 318 4.4 49 1.6 54
Spectral analysis
VLF LF HF VLF% (AR) LF% (AR) HF% (AR) TP LF/HF (AR)
5‰ 20 122 38 9 65 15 178 2.7
95‰ 99 478 138 15 73 23 697 4.6
Table 5. Integrated period. Lower (5‰) and upper (95‰) percentile limits of the fetal HRV time parameters.
Obstetrics30
The analysis of the time parameters revealed no impairment of the scattering or concentra-
tion functions (5–95‰). The time analysis indices did not go beyond the percentile limits. 
The spectral analysis permitted to identify vegetal balance with the total power up (>95‰) 
of the spectrum (Figure 9). However, it cannot be treated as a fetal hypoxia sign, which is 
Figure 8. A gestation period of 40 weeks. Fetal cardiorythmograms, stationary period and physiological monotonicity 
(Y-axis—RR intervals, ms; X-axis—count).
Scattering function
SDNN rMSSD NN15 pNN15% VR
5–95‰ 0.006–0.012 0.004–0.01 4–35 0.51–5.08 0.04–0.097
sleep 0.008 0.007 23 3.3 0.06
Concentration function
NModa AMo Moda
range
% AMo/PNN15 St. George 
Index
5–95‰ 32–90 5.0–12.9 48–87 0.5–4.7 13–35
sleep 51 7.3 52 2.2 27
Spectral analysis
VLF LF HF VLF% 
(AR)
LF% (AR) HF% (AR) TP LF/HF (AR)
5–95‰ 0.3–2.9 1.9–18.8 1.3–5.8 5–11 49–78 12–40 4.3–18.5 1.15–3.96
sleep 1.2 15 9.6* 5 58 37 26* 1.6
ECG morphology
P Q R S T QRS STint ST
5–95‰ 0.39–2.14 −4.3 to 
−0.21
3.6–18.3 −7.96 to 
0.02
0.39–1.72 44–58 18–66 −0.2 to 0.6
sleep 0.843 −2.41 11.8 −2.41 0 51 − −0.12
Note: *Parameters exceed the 5–95‰ limits.
Table 6. Time and frequency analysis parameters and ECG morphology in the presence of physiological monotonicity.
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confirmed by normal indicators of the fetus ECG (5–95‰) (Figures 8 and 10). Facing this type 
of monotonicity, we can affirm that the risk of hypoxic damage assessed on the basis of time 
and frequency analysis parameters is low (4 points).
3.2.2. Pharmacological monotonicity: atropine
Atropine, a muscarinic receptor antagonist, reduces the vagal tone increasing the heart rate 
and raising conductivity along the His band. It is targeted toward the sino-atrial node causing 
Figure 9. Spectral analysis of frequency (FFT method). A period of 40 week gestation, normal fetus. stationary period, 
physiological monotonicity.
Figure 10. ECG. A period of 40 week gestation, normal fetus, stationary period, physiological monotonicity.
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fetal heart rate monotonicity by increasing the activity of the sympathetic nervous system. 
The following is data analysis of the patient with 41 week gestation: planned labor induction; 
epidural anesthesia, cephalopelvic disproportion and caesarean section. Delivery of a baby 
boy, 4190 g, 56 cm, 8/9 Apgar score. Medicines used: atropine. Stationary period lasted for 5 
minutes or 700 counts duration (Figure 11 and Table 7).
The analysis of the time domain parameters revealed no impairment of the scattering or con-
centration functions (5–95‰). The time analysis indices did not go beyond the percentile lim-
its. The spectral analysis permitted to identify the total power up (>95‰) of the spectrum and 
the accentuated decrease of the high-frequency spectrum component (<5‰) which reflects the 
weakening of parasympathetic influences over the heart (Figure 12). Accentuated sympathi-
cotonia is confirmed by a significant increase in the high-to low-frequency spectrum compo-
nents ratio (>95‰). The fetal ECG parameters including the ST segment do not go beyond the 
percentile limits (5–95‰), which speaks for the absence of fetal hypoxia (Figure 13). With this 
type of monotonicity, the risk of hypoxic damage assessed on the basis of time and frequency 
analysis parameters is moderate (5 points).
3.2.3. Pharmacological monotonicity: methyldopa
Methyldopa, which is a stimulant of the alpha-adrenoceptors, causes fetal heart rate monoto-
nicity by suppressing the activity of the central fetal heart rate regulation mechanisms.
The following is data analysis of the patient with 39 week gestation: arterial hypertension, 
labor induction, delivery of a baby girl, 3090 g, 52 cm, 9/9 Apgar score. Medicines used: meth-
yldopa starting from week 32. Stationary period lasted for 5 minutes 700 counts duration, 
(Figure 14 and Table 8).
The analysis of the time parameters revealed the intensification of the sympathetic influences 
which resulted in the increase of the concentration function (>95‰). The spectral analysis 
permitted to identify the increase of the high-frequency spectrum component (>95%) with a 
background of the total power down of the spectrum, which testifies for the predominance 
of parasympathetic influences over the heart (Figure 15). Accentuated vagotony is confirmed 
Figure 11. A period of 41 week gestation, fetal cardiorythmograms, stationary period, pharmacological monotonicity, 
atropine effect (Y-axis—RR intervals, ms; X-axis—count).
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Scattering function
SDNN rMSSD NN15 pNN15% VR
5–95‰ 0.006–0.012 0.004–0.01 4–35 0.51–5.08 0.04–0.097
atropine 0.011 0.006 30 4.30 0.07
Concentration function
NModa AMo Moda
range
% AMo/PNN15 St. George 
Index
5–95‰ 32–90 5.0–12.9 48–87 0.5–4.7 13–35
atropine 57 8.2 58 1.9 22
Spectral analysis
VLF LF HF VLF% 
(AR)
LF% (AR) HF% (AR) Power 
(AR)
LF/HF (AR)
5–95‰ 0.3–2.9 1.9–18.8 1.3–5.8 5–11 49–78 12–40 4.3–18.5 1.15–3.96
atropine 1.6 14 1.9 13* 76 11* 19* 7.2*
ECG morphology
P mv Q mv R mv S mv T mv QRS ms Stint ms ST mv
5–95‰ 0.39–2.14 −4.3 to 
−0.21
3.6–18.3 −7.96 to 
−0.02
0.39–1.72 44–58 18–66 −0.2 to 0.6
atropine 3.08* −11.8 32.4* −10.1 1.64 51 33 −0.2
Note: *Parameters exceed the 5–95‰ limits.
Table 7. Time and frequency analysis parameters and ECG morphology in the presence of pharmacological monotonicity— 
atropine.
Figure 12. Spectral analysis of frequency (FFT method). A period of 41 week gestation, normal fetus, stationary period, 
pharmacological monotonicity, atropine.
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by a significant decrease in the high to low-frequency spectrum components ratio (<5‰). 
However, it cannot be treated as a fetal hypoxia sign. The fetal ECG parameters do not go 
beyond the percentile limits (5–95‰) (Figure 16). With this type of monotonicity, the risk of 
hyoxic damage assessed on the basis of time and frequency analysis parameters is moderate 
(6 points).
Figure 13. ECG. A period of 41 week gestation, normal fetus, stationary period, pharmacological monotonicity—atropine.
Figure 14. A period of 39 week gestation, fetal cardiorythmograms, stationary period, pharmacological monotonicity, 
methyldopa effect (Y-axis—RR intervals, ms; X-axis—count).
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Figure 15. Spectral analysis of frequency (FFT method). A period of 39 week gestation, normal fetus, stationary period, 
pharmacological monotonicity, methyldopa.
Scattering function
SDNN rMSSD NN15 pNN15% VR
5–95‰ 0.006–0.012 0.004–0.01 4–35 0.51–5.08 0.04–
0.097
methyldopa 0.006 0.006 21 3.01 0.07
Concentration function
NModa AMo Moda
range
% AMo/PNN15 St. 
George 
Index
5–95‰ 32–90 5.0–129 48–87 0.5–4.7 13–35
methyldopa 137* 19.6* 61 6.5* 10*
Spectral analysis
VLF LF HF VLF% (AR) LF% (AR) HF% (AR) Power 
(AR)
LF/HF 
(AR)
5–95‰ 0.3–2.9 1.9–18.8 1.3–5.8 5–11 49–78 12–40 4.3–18.5 1.15–3.96
methyldopa 0.134* 2.32 1.74 9.28 46* 45* 5.1 1.0*
ECG morphology
P Q R S T QRS STint ST
5–95‰ 0.39–2.14 −4.3 to 0.21 3.6–18.3 −7.96 to 0.02 0.39–1.72 44–58 18–66 −0.2 to 
0.6
methyldopa 0.76 −1.62 7.09 −0.86 0.55 51 55 −0.2
Note: *Parameters exceed the 5–95‰ limits.
Table 8. Time and frequency analysis parameters and ECG morphology in the presence of pharmacological monotonicity— 
methyldopa.
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3.2.4. Medication sleep (promedol and relanium)
Both promedol and relanium cause fetal heart rate monotonicity by depressing the central ner-
vous system of the fetus. Here, you see data analysis of the patient with 40 week gestation, uter-
ine scar, planned labor induction, medication sleep, delivery of a baby boy, 3600 g, 53 cm, 9/9 
Apgar score. Medicines used: promedol and relanium. Stationary period lasted for 5 minutes 
or 700 counts duration (Table 9 and Figure 17).
The analysis of the time parameters revealed no impairment of the scattering and concentra-
tion functions. The time analysis indices do not go beyond the percentile limits (5–95‰). 
The spectral analysis permitted to identify vegetal balance with the normal spectrum power 
(5–95‰) (Figure 18). The fetal ECG parameters do not go beyond the percentile limits (5–95‰) 
(Figure 19). With this type of monotonicity, the risk of hypoxic damage assessed on the basis 
of time and frequency analysis parameters is low (3 points).
3.2.5. Hypoxic monotonicity
Lack of vegetal balance leads to an extreme increase of adrenergic influences over vascular 
walls, which ultimately results in the predominance of cholinergic influences, and this 
process causes circulatory hypoxia followed by a change in the arterial blood gas as well 
as pH.
Figure 16. ECG. A period of 39 week gestation, normal fetus, stationary period, pharmacological monotonicity, methyldopa.
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3.2.5.1. Heart failure
The following is data analysis of the patient with 40 week gestation: arterial hypertension, 
atrial septal defect (12 mm), inferior vena cava dilation (10 mm), ascite confirmed by ultra-
sound fetometry. “Zero” blood flow in the umbilical artery, PI-1.77. Fetus weight: 3530 g. 
Caesarean section caused by fetal distress in labor. Stationary period lasted for 5 minutes or 
700 counts (Figure 20 and Table 10).
Scattering function
SDNN rMSSD NN15 pNN15% VR
5–95‰ 0.006–0.012 0.004–0.01 4–35 0.51–5.08 0.04–0.097
Med. sleep 0.008 0.007 35 5.01 0.06
Concentration function
NModa AMo Moda
range
% AMo/PNN15 St. George 
Index
5–95‰ 32–90 5.0–12.9 48–87 0.5–4.7 13–35
Med. sleep 84 12.0 67 2.4 17
Spectral analysis
VLF LF HF VLF% 
(AR)
LF% (AR) HF% (AR) Power 
(AR)
LF/HF (AR)
5–95‰ 0.3–2.9 1.9–18.8 1.3–5.8 5–11 49–78 12–40 4.3–18.5 1.15–3.96
Med. sleep 0.398 3.47 3.05 5.69 55 39 6.5 1.37
ECG morphology
P Q R S T QRS STint ST
5–95‰ 0.39–2.14 −4.3 to 0.21 3.6–18.3 −7.96 to 
0.02
0.39–1.72 44–58 18–66 −0.2 to 0.6
Med. sleep 0.92 −1.54 13.51 −2.32 1.09 45 27 −0.07
Table 9. Time and frequency analysis parameters and ECG morphology in the presence of pharmacological monotonicity— 
promedol and relanium.
Figure 17. A period of 40 week gestation, fetal cardiorythmograms, stationary period, pharmacological monotonicity, 
promedol and relanium (Y-axis— RR intervals, ms; X-axis—count).
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3.2.5.2. Fetal infection
The following is data analysis of the patient with 40 week gestation: monotonous fetal heart 
rate, labor induction, caesarean section caused by fetal head asynclitism; delivery of a baby boy, 
3650 g, 51 cm, 6/7 Apgar score; venous blood pH: 7.054; neonatologist’s diagnosis: congenital 
Figure 18. Spectral analysis of frequency (FFT method). A period of 40 week gestation, normal fetus, stationary period, 
pharmacological monotonicity, relanium and promedol.
Figure 19. ECG. A period of 40 week gestation, normal fetus, stationary period, pharmacological monotonicity, relanium, 
promedol.
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pneumonia; respiratory failure, stage III; mixed genesis shock; and stationary period lasted for 
5 minutes or 700 counts (Figure 21 and Table 11).
The analysis of the time parameters revealed a radical decrease of the scattering function 
(<5‰) alongside with a sharp increase of the concentration function (>95‰). This speaks 
for significant sympathetic influences over the cardiovascular system. The spectral analysis 
Figure 20. A period of 40 week gestation, fetal cardiorythmograms, stationary period, hypoxic monotonicity (Y-axis—
RR intervals, ms; X-axis—count).
Scattering function
SDNN rMSSD NN15 pNN15% VR
5–95‰ 0.006–0.012 0.004–0.01 4–35 0.51–5.08 0.04–0.097
Hypoxia 0.005* 0.006 25 3.58 0.05
Concentration function
NModa AMo Moda
range
% AMo/PNN15 St. George Index
5–95‰ 32–90 5.0–12.9 48–87 0.5–4.7 13–35
Hypoxia 173* 24.8* 50 6.92* 8*
Spectral analysis
VLF LF HF VLF% 
(AR)
LF% (AR) HF% (AR) Power 
(AR)
LF/HF (AR)
5–95‰ 0.3–2.9 1.9–18.8 1.3–5.8 5–11 49–78 12–40 4.3–18.5 1.15–3.96
Hypoxia 0.13 0.487* 1.86 3.85 33* 63* 2.23* 0.53*
ECG morphology
P Q R S T QRS STint ST
5–95‰ 0.39–2.14 −4.3 to 
−0.21
3.6–18.3 −7.96 to 
−0.02
0.39–1.72 44–58 18–66 −0.2 to 0.6
Hypoxia 1.14 −1.26 7.97 −1.71 0.654 52 42 −0.7*
Note: *Parameters exceed the 5–95‰ limits.
Table 10. Time and frequency analysis parameters and ECG morphology in the presence of hypoxic monotonicity.
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permitted to identify the increase of the high-frequency spectrum component (>95‰) with 
a background of the total power down of the spectrum (<5‰), which testifies for the pre-
dominance of parasympathetic influences over the heart (Figure 22). Accentuated vagotony 
is confirmed by a significant decrease in the ratio of high to low frequency components of the 
spectrum (<5‰). Fetal ECG analysis shows depression of the ST segment, which is indicative 
of fetal hypoxia (<5‰) (Figure 23). With this type of monotonicity, the risk of hypoxic dam-
age assessed on the basis of time and frequency analysis parameters is very high (9 points).
Figure 21. A period of 40 week gestation, fetal cardiorythmograms, stationary period, hypoxic monotonicity (Y-axis—
RR intervals, ms; X-axis—count).
Scattering function
SDNN rMSSD NN15 pNN15% VR
5–95‰ 0.006–0.012 0.004–0.01 4–35 0.51–5.08 0.04–0.097
Hypoxia 0.005* 0.005 21 3.01 0.06
Concentration function
NModa AMo Moda
range
% AMo/PNN15 St. George 
Index
5–95‰ 32–90 5.0–12.9 48–87 0.5–4.7 13–35
Hypoxia 125* 17.9* 51 5.95* 11*
Spectral analysis
VLF LF HF VLF% 
(AR)
LF% (AR) HF% (AR) Power 
(AR)
LF/HF 
(AR)
5–95‰ 0.3–2.9 1.9–18.8 1.3–5.8 5–11 49–78 12–40 4.3–18.5 1.15–3.96
Hypoxia 0.18* 2.51 1.86 6.62 44* 50* 3.52* 0.88*
ECG morphology
P Q R S T QRS STint ST
5–95‰ 0.39–2.14 −4.3 to 
−0.21
3.6–18.3 −7.96 to 
−0.02
0.39–1.72 44–58 18–66 −0.2 to 0.6
Hypoxia 1.63 −3.01 20* −7.71 − 52 54 −1.44*
Note: *Parameters exceed the 5–95‰ limits.
Table 11. Time and frequency analysis parameters and ECG morphology in the presence of hypoxic monotonicity.
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4. Conclusion
Heart rate variability (HRV) is a CTG parameter considered important for fetal monitoring 
[9–12]. A monotonous heart rate is deemed an adverse prognostic parameter. A few scientific 
Figure 22. Spectral analysis of frequency (FFT method). A period of 40 week gestation. Fetometry: atrial septal defect 
(12 mm), inferior vena cava dilation (10 mm), ascite. “Zero” blood flow in the umbilical artery, PI-1.77. Stationary 
period and hypoxic monotonicity.
Figure 23. ECG. A period of 40 week gestation. Fetometry: atrial septal defect (12 mm), inferior vena cava dilation (10 mm), 
ascite. “Zero” blood flow in the umbilical artery, PI-1.77. Stationary period and hypoxic monotonicity.
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papers devoted to fetal state distortion point at HRV decrease in the presence of fetal distress 
[6, 7]. However, other research investigations confirm that HRV decrease is possible during 
the dormant period of the fetus as well as when its nervous system is suppressed by pharma-
ceuticals. The understanding of the HRV physiological mechanism is not complete. It is widely 
accepted that the central nervous system dominates HRV regulation [13, 14]. The activity of 
the autonomic nervous system can be viewed as a brain function marker reflecting the regula-
tory capacity of the central nervous system [15]. Fetal autonomic nervous system activity is 
assessed on the basis of the time and frequency analysis of the RR intervals temporal series.
Beat-to-beat heart rate registration is a reliable source of data on the HRV spectrum [16, 17] 
and an indispensable prerequisite for correct interpretation of the fetal cardiogram. The com-
plex wave structure of the fetal cardiorythmogram stipulates for the use of the time and fre-
quency domain methods when analyzing vague CTGs. The majority of papers focused on 
the study of fetal state distortion by using the methods of time and frequency analysis have 
respect to the diagnostics of fetal distress during childbirth [7, 8, 12, 18–21]. We, however, 
believe that it is of utmost importance to monitor the fetus in the late weeks of gestation. We 
have defined percentile limits of the time and frequency analysis parameters required for fetal 
monitoring during the last weeks of pregnancy. The proposed diagnostic scale of fetal HRV 
time and frequency parameters permits to define the risk of anoxic damage when facing CTGs 
deemed alarming, including the cases of heart rate monotonous.
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